Trump Administration Plans New Drug Pricing Deals With Biotech Firms 
BNP Paribas, KB Kookmin Eye $2 Billion Techcombank Stake 
Google Changes EU Spam Policy Amid Antitrust Scrutiny 
Trian Drops Wendy’s Take-Private Bid Plans, Shares Plunge 14% 
Nvidia Pauses AI Cloud Financing Deals Amid Antitrust Concerns 
Meta, U.S. States Discuss Settlement in Teen Addiction Trial 
U.S. Probes Apex Logistics Over Nvidia AI Chip Shipments to China 
OpenAI AI Agent Swarm Behind Hugging Face Hack 
Mercer International Stock Surges 45% on C$20 Million Canada Funding 
Nvidia Revenue Soars 106% as AI Demand Hits ‘Inflection Point’ 
Shein Hong Kong IPO to Raise $1.7 Billion at $26.5 Billion Valuation 
The Realist’s Case: Lukas Kerrebijn of RD Dubai on the Narrative Dubai’s Agents Won’t Question 
Salesforce Shares Surge as AI Demand Powers Q2 Earnings Beat 
Nvidia Reportedly Eyes $13 Billion Hugging Face Acquisition 
HP Stock Drops 9% Despite Q3 Earnings Beat and Raised 2026 Outlook 
Street Poller Media and The Boom of the Street Interview Ad Industry 
Toyota Global Sales Fall as China Demand Slumps 
Add as a preferred source on Google
CAMBRIDGE, Mass., April 05, 2018 -- Wave Life Sciences Ltd. (NASDAQ:WVE), a biotechnology company focused on delivering transformational therapies for patients with serious, genetically-defined diseases, today announced that Paul Bolno, MD, MBA, President and Chief Executive Officer, will be participating at the following conferences:
| H.C. Wainwright & Co. Global Life Sciences Conference April 9th at 9:00 a.m. CEST – Monte Carlo, Monaco Leerink Partners’ CNS Day April 18th at 10:00 a.m. EST – New York, NY |
About Wave Life Sciences
Wave Life Sciences is a biotechnology company focused on delivering transformational therapies for patients with serious, genetically-defined diseases. Our chemistry platform enables the creation of highly specific, well characterized oligonucleotides designed to deliver superior efficacy and safety across multiple therapeutic modalities. Our pipeline is initially focused on neurological disorders and extends across several other therapeutic areas. For more information, please visit www.wavelifesciences.com.
Investor Contact:
Jillian Connell
617-949-2981
[email protected]
Media Contact:
Jose Juves
617-949-4708
[email protected]
